Aggregations of proteins are in many cases associated with neurodegenerative diseases such as Alzheimer's (AD). Small compounds capable of inhibiting protein aggregation are expected to be useful for not only in the treatment of disease but also in probing the structures of aggregated proteins. In previous studies using phage display, we found that arginine-rich short peptides consisting of four or seven amino acids bound to soluble 42-residue amyloid (A42) and inhibited globulomer (37/48 kDa oligomer) formation. In the present study, we searched for arginine-containing small molecules using the SciFinder searching service and tested their inhibitory activities against A42 aggregation, by sodium dodecyl sulfate (SDS)-PAGE and thioflavine T binding assay. Commercially available Arg-Arg-7-amino-4-trifluoromethylcoumarin was found to exhibit remarkable inhibitory activities to the formation of the globulomer and the fibril of A42. This chimera-type tri-peptide is expected to serve as the seed molecule of a potent inhibitor of the A aggregation process.
The processes by which proteins aggregate into amyloid fibrils are in many cases associated with neurodegenerative disorders. 1) Amyloid (A) is wellknown to aggregate into fibrils, an important hallmark of Alzheimer's disease (AD), and the development of effective medicines to target the aggregation of A is under way all over the world. 2, 3) It was suggested recently that soluble oligomers of A as well as the fibrils are toxic to neuronal cells. 4) Although it is necessary for structural and physiological studies to prepare a homogeneous A protein in vitro, most soluble oligomers are of various molecular sizes (from 10 kDa to 100 kDa). Among the soluble oligomers reported, globulomer (37/48 kDa, apparent mass of two bands on SDS-PAGE gel) can be prepared reproducibly and homogeneously in the presence of sodium dodecyl sulfate (SDS) or fatty acids in vitro, and it binds to the hippocampal neurons of rat brain tissue and blocks long-term potentiation at an early stage of AD. 5) Hillen et al. generated a monoclonal antibody against globulomer and suggested the possibility that antibody is effective for therapy in AD. 6) This strategy is based on the concept that suppression of function of the resulting toxic oligomers is effective for the reduction of amyloid toxicity. On the other hand, we have focused on forestalling soluble oligomer formation, and have screened compounds that inhibit the production of toxic globulomer. 7, 8) Globulomer is perhaps not an intermediate of A fibril formation, as indicated by solution NMR analysis. 9, 10) Therefore, at least two kinds of toxic soluble oligomers of A are present in the brain cells of AD patients, globulomer, and soluble oligomers produced during the course of fibrillation. In order to reduce the toxic A molecule completely, drugs capable of inhibiting both globulomer and fibril formation are considered to be effective. 11 ) Also, such a doublefunctional compound is expected to be useful for analysis of the aggregation mechanism of A.
We recently found that arginine-rich short peptides (four or seven residues) bind to soluble 42-residue amyloid (A42) and inhibit globulomer formation using phage display. 7, 8) A tetra-peptide, RFRK, strongly inhibits globulomer formation, and the important factor for inhibitory activity is considered to be arginine residues, as found in previous studies. Although this peptide is expected to be useful in inhibiting toxic globulomer formation, its effect on A fibril formation is small. 8) We seek to discover a small molecule that has inhibitory activities against both globulomer and a fibril of A, because such a molecule is expected to be useful in the development of lead compounds for the reduction of A toxicity. Most recently, coumarin (2H-chromen-2-one), an aromatic molecule found in cinnamon-flavored foods, has been reported to inhibit A fibril formation.
12)
However, it is not yet known whether coumarin inhibits the globulomer formation of A42. Further, a hybrid compound that has both a coumarin moiety and arginine residues within it is expected to exhibit to reduce the aggregated form of A. Hence we screened hybridstructured molecules capable of inhibiting A aggregation from commercially available products. One convenient screening method is to use the SciFinder on-line service.
We found that a chimera-type tri-peptide containing both di-arginine and coumarin bodies, found by the on-line service, inhibited A42 aggregation strongly, as expected.
Materials and Methods
Materials. A42 was purchased from the Peptide Institute (Osaka, Japan). HFIP (hexafluoroisopropyl alcohol), DMSO (dimethyl sulfoxide), SDS (sodium dodecyl sulfate), and ThT (thioflavine T) were from Nacalai Tesque (Kyoto, Japan). Arg-Arg-7-amino-4-trifluoromethylcoumarin and Z-Arg-Arg-thiobenzyl ester were from MP Biomedicals. (Irvin, CA). 7-Amino-4-methylcoumarin (AMC) was from Nacalai Tesque. Polyacrylamide gel (SuperSepÔ Ace 5-20%) were from Wako Pure Chemical Industries (Osaka, Japan). Peptides were from PHJapan (Hiroshima, Japan). The LC-MS data for the synthesized peptides are shown in the Supplemental data (see Biosci. Biotechnol. Biochem. Web site).
Preparation of soluble oligomers of A42. A42 (0.56 mg) was dissolved in 0.27 mL of hexafluoroisopropyl alcohol (HFIP) and dried in vacuo.
5) The dried pellet was redissolved in dimethyl sulfoxide (DMSO) at 1.0 mM as stock solution. To prepare globulomer of A42, the stock solution was immediately diluted with phosphate-buffered saline (PBS, composed of 137 mM NaCl, 2.7 mM KCl, 12 mM Na 2 HPO 4 , and 1.2 mM KH 2 PO 4 at pH 7.4) to 200 mM (DMSO, 20%), and this was incubated with 0.1% SDS at 37 C for 4 h in the presence of peptides or small molecules. To detect the A42 globulomer, the solutions (7 mL) were applied to SDS-PAGE (5-20%) without heat denatures and the gel was stained with Coomassie. Small molecules were dissolved in DMSO at 40 mM as stock solutions and diluted with PBS at appropriate concentrations. Short peptides were dissolved in PBS in 10 mM stock solutions.
Preparation of A42 fibrils and ThT binding assay. The dried pellets of A42 after dissolving it in HFIP were redissolved in DMSO at 5.0 mM as stock solution. The solution was diluted with PBS to 0.2 mM (DMSO, 4%) and incubated at 37 C for 24 h in the presence of the small molecules. The solution was diluted to a final concentration of 8.0 mM in PBS and combined with 10 mM ThT reagent. 13) After 10 min of reaction at room temperature, the fluorescence intensity was measured at 492 nm using an excitation wavelength of 450 nm on micro-plate reader MTP800AFC (Corona, Hitachinaka, Japan).
Search for small molecules using SciFinder. We logged into the web version (https://scfinder.cas.org) of SciFinder, then drew the chemical structure of arginine on the display of substances to be searched, and searched for commercially available compounds containing arginines.
Results

Inhibitory effects of small molecules containing arginines on the aggregation of A42
As the upshot of searching for compounds containing arginines, a total of 2,950 molecules were displayed, and several small molecules that had molecular weights of about 500 Da were chosen. Among these, we found a coumarin-containing compound, Arg-Arg-7-amino-4-trifluoromethylcoumarin (RR-AFC, molecular weight 541 Da) (Fig. 1A) . Another di-arginine derivative, ZArg-Arg-thiobenzyl ester (Z-RR-SBzl, molecular weight 570 Da), was chosen as a reference molecule, because it contained both di-arginine and aromatic groups. RR-AFC contains two arginines and one coumarin moiety. It is used in the assay of neuronal protease activity. 14) Z-RR-SBzl also contains two arginines, but is protected by aromatic groups at the N-and C-terminals. These compounds were tested for inhibition of globulomer of A42 by SDS-PAGE (Fig. 1B) . As a positive control, RFRK was used. 8) Globulomer was clearly seen between the 37-and the 48 kDa marker protein after 4 h of incubation of A42 (0.2 mM) alone (lanes a and b). A monomer (4,514 Da) and a tetramer (18,056 Da), which was seen below the 21-kDa marker protein, were also decreased in amount after incubation. These bands of A42 were repeatedly detected on the gel. 5, 7, 8) On the contrary, globulomer was largely reduced, and instead the monomer and the tetramer remained, in the presence of RR-AFC at a concentration of 1.0 mM (lane c). In the case of a concentration of RR-AFC below 0.5 mM, the globulomer was reduced to approximately half (lanes d and e). These tendencies were almost the same as those for RFRK (lanes i, j, and k). On the other hand, globulomer was seen in the presence of Z-RR-SBzl even at a concentration of 1.0 mM, and it was little inhibited by a concentration of 0.2 mM (lanes f, g, and h). This indicates that Z-RR-SBzl has a weaker effect than RR-AFC on the inhibition of globulomer. Both compounds have arginines and aromatic rings, but the N-terminal of Z-RR-SBzl is blocked by a Z-group and that of RR-AFC is free. In the case of Z-RR-SBzl, a large benzylo- xycarbonyl (Z) group at the N-terminal might perturb the interaction of arginine with A42, and so its binding and inhibitory activities are considered to be somewhat weak.
The concentrations of the peptides tested in this study were higher than those of reagents in drug development (on the order of mM). We used sufficiently high concentrations of A42 to be detected by SDS-PAGE.
Next, we tested to determine whether coumarin alone inhibits globulomer formation. We purchased 7-amino-4-methylcoumarin (AMC), since 7-amino-4-trifluoromethylcoumarin (AFC) could not be obtained in practical terms. We assumed that the trifluoromethyl group is functionally equal to the methyl group of the coumarin body with regard to molecular size. AMC was dissolved in DMSO, and the solution was diluted with PBS at concentrations of 0.2-1.0 mM, and this was incubated with A42 (0.2 mM) solutions in the presence of 0.1% SDS. In Fig. 2A , while RR-AFC inhibited globulomer dose-dependently (lanes c, d, and e), AMC did not inhibit it even at a concentration of 1.0 mM (lanes f, g, and h). This indicates that the coumarin moiety does not inhibit the globulomer formation. It can be considered that the R-R moiety of RR-AFC is important in inhibiting the globulomer formation of A42, as found in previous studies. 7, 8) In the presence of RR-AFC at a concentration of 1.0 mM (lane c), both the tetramer and the pentamer (22,570 Da) were also reduced somewhat as compared to the solution of A42 alone (lane a). This indicates that RR-AFC also inhibits low-molecular weight oligomer formation, including the tetramer and the pentamer of A42. However, the dimer and the trimer, which have also been reported to be neurotoxic, were not detected by this method, and it is not known whether RR-AFC inhibits the formation of small oligomers. 15, 16) Coumarin derivatives are known to affect fibril formation by A42. 12) Hence we tested to determine whether RR-AFC and AMC inhibit A42 fibril formation using ThT reagent (Fig. 2B) . 17 ) A42 (0.2 mM) was incubated with RR-AFC (1.0 mM) or AMC (1.0 mM) for 32 h at 37 C. The fluorescence signal from the ThT reagent reached about 1,000 AU in the case of A42 alone (diamond) at 32 h of incubation. On the contrary, those signals were reduced to about 1/2 in the presence of RR-AFC (square) at 24 h and 32 h of incubations. AMC also reduced the fluorescence signal to the same level (triangle). These results indicate that RR-AFC as well as AMC inhibits the fibril growth of A42, although those inhibitory effects were weak. However, at 8 h of incubation, A fibril formation was not inhibited by either compound. This indicates that both RR-AFC and AMC have little inhibitory activity against the formation of seeds of A fibrils. RR-AFC inhibited both the globulomer formation and the fibril growth of A42. On the other hand, AMC affected the fibril only, and hardly inhibited globulomer formation ( Fig. 2A) . These results indicate that globulomer formation is a different process from fibril formation, and confirm the A aggregation mechanism hypothesized by Barghorn et al. 18) They clarified that globulomer formed independently of fibril formation, using Congo red reagent. Both coumarin and Congo red are aromatic compounds that intercalate between -sheet structures via hydrophobic interactions. Consequently, the globulomer is probably formed by hydrophilic driving forces, rather than the hydrophobic interactions that are main causes of fibril formation.
Inhibitory effects of RR-n tri-peptides on the aggregation of A42
The molecular size of RR-AFC is almost the same as those of natural RR-n tri-peptides (n indicates any one of 20 amino acids). It is possible that some RR-n tripeptides have the same inhibitory activities to globulomer as RR-AFC. Hence 20 RR-n tri-peptides were tested for inhibitory activity (Fig. 3A) . Some tri-peptides were found to inhibit globulomer formation to about half level of the activity of RR-AFC (lanes l and x). RR-F (lane e), RR-W (lane j), RR-E (lane n), RR-R (lane t), and RR-I (lane u) were weak inhibitors. These results indicate that not only the chromene ring, but also the phenyl ring, indole, and large side chains in tripeptides have important roles in inhibiting globulomer formation. Finally, the inhibition by tri-peptides of the fibrillation of A42 was tested using ThT reagents, as described above (Fig. 3B) . At the 24 h of incubation of A42 with tri-peptides, almost all the fluorescent signals of the solutions, except for RR-D (g) and RR-W (j), were at 600-800 AU, almost same levels as that of A42 alone (a). This indicates that RR-D and RR-W had significant inhibitory activities, as well as RR-AFC (v). As for the inhibitory activity of RR-W, it can be concluded that the tryptophan ring has a role similar to the chromene ring, because both groups are aromatics. On the other hand, as for the activity of RR-D, it can be concluded that salt bridges between RR-D molecules are formed and affect the association of A molecules, but further examination is necessary to determine the inhibition mechanism.
Discussion
We succeeded for the first time in identifying an active compound, RR-AFC, that can inhibit both globulomer and fibril aggregations of A42. In previous studies, phage display was used to screen the binding of molecules to A42, an active tetra-peptide, RFRK, was found. 7, 8) This tetra-peptide strongly inhibited globulomer formation, but had little effect on A fibril formation. Thus, RR-AFC is better than RFRK for inhibition of the aggregation of A42. Although phage display is useful in acquiring essential peptide sequences from random libraries, there are several limitations, as for obtaining novel compounds. First, the compounds are limited to structures including 20 amino acids. Secondly, there is a bias in the custom-synthesized random library, due to the synthetic efficiency of
On the other hand, chemical libraries, including ones for natural and synthetic products, are available to obtain non-peptide compounds. They are provided by for example the Open Innovation Center for Drug Discovery of The University of Tokyo. SciFinder is considered to be most convenient on-line service for the screening chemical compounds. We decided to use SciFinder by reason of convenience to discover functional compounds.
In a structural study by Yu et al. using solution NMR, acidic residues (E22-D23) had important roles in the formation of glubulomer of A42, and the detergent, SDS, induced conformational changes in the A molecule. 9) Our results indicate that RR-AFC inhibits both globulomer and A fibrils, while coumarin inhibits fibrils only. Based on these results, it can be concluded that the Arg-Arg region is necessary to inhibit globulomer formation via ionic interactions, and that another AFC moiety has a role in interrupting the hydrophobic interactions of A molecules via -stacking interactions. 12) Since SDS is a strong ionic detergent, it can be also concluded that RR-AFC binds specifically to the acidic region including E22-D23 and protects the conformation of A from the detergent.
As found by Glabe et al., small molecules are useful in the characterization of the aggregation of A. 11) They tested about 40 compounds for inhibition of A42 aggregation, and proposed two distinct aggregation pathways of A, a soluble oligomer formation pathway and a fibril formation pathway. Our results also indicate that globulomer formation is a process different from fibril formation, as confirmed using the above tripeptides inhibitors.
In conclusion, we found that a chimera-type tripeptide, Arg-Arg-coumarin, inhibited both the formation of globulomer and that of fibrils of A42. It is to be expected that this small compound will prove useful in developing a potent seed molecule for suppression of toxic oligomers of A42. C for 4 h. The solutions were applied on the gradient SDS-PAGE gel without heat denaturing. a, A42 only; b, A42 with RRM; c, A42 with RRL; d, A42 with RRG; e, A42 with RRF; f, A42 with RRK; g, A42 with RRD; h, A42 with RRV; i, A42 with RRA; j, A42 with RRW; k, A42 with RRC; l, A42 with RR-AFC; m, A42 only; n, A42 with RRE; o, A42 with RRN; p, A42 with RRQ; q, A42 with RRT; r, A42 with RRS; s, A42 with RRP; t, A42 with RRR; u, A42 with RRI; v, A42 with RRY; w, A42 with RRH; x, A42 with RR-AFC. B, Effects of tri-peptides on fibril formation by A42. Solutions (10 mL) containing A42 (0.2 mM) with compounds (0 or 1.0 mM) in PBS (DMSO: 4%) were incubated at 37 C for 24 h. The resulting solution was mixed with ThT reagent, and the fluorescent intensities were measured as described under ''Materials and Methods.'' Assays were performed 3 times, and average values are given. a, A42 only; b, A42 with RRM; c, A42 with RRL; d, A42 with RRG; e, A42 with RRF; f, A42 with RRK; g, A42 with RRD; h, A42 with RRV; i, A42 with RRA; j, A42 with RRW; k, A42 with RRC; l, A42 with RRE; m, A42 with RRN; n, A42 with RRQ; o, A42 with RRT; p, A42 with RRS; q, A42 with RRP; r, A42 with RRR; s, A42 with RRI; t, A42 with RRY; u, A42 with RRH; v, A42 with RR-AFC.
